Related references
Note: Only part of the references are listed.Regulation of different inflammatory diseases by impacting the mevalonate pathway
Robert Zeiser et al.
IMMUNOLOGY (2009)
Statins inhibit human APC function: implications for the treatment of GVHD
Alexander Shimabukuro-Vornhagen et al.
BLOOD (2008)
The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation
Mehdi Hamadani et al.
BLOOD (2008)
Graft-versus-host disease: suppression by statins
Raewyn Broady et al.
NATURE MEDICINE (2008)
Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity
Robert Zeiser et al.
BLOOD (2007)
Atorvastatin inhibits T cell activation through 3-hydroxy-3-methylglutaryl coenzyme a reductase without decreasing cholesterol synthesis
Norbert Blank et al.
JOURNAL OF IMMUNOLOGY (2007)
Atorvastatin interferes with activation of human CD4+ T cells via inhibition of small guanosine triphosphatase (GTPase) activity and caspase-independent apoptosis
P. -T. Brinkkoetter et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Statin therapy and autoimmune disease: from protein prenylation to immunomodulation
J Greenwood et al.
NATURE REVIEWS IMMUNOLOGY (2006)
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes
LM Blanco-Colio et al.
CIRCULATION (2003)
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies
MB Maris et al.
BLOOD (2003)
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
G Weitz-Schmidt et al.
NATURE MEDICINE (2001)
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
PA McSweeney et al.
BLOOD (2001)